Status:
UNKNOWN
Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Objectives: To elucidate the effects of achieving sustained simple disease activity index (SDAI) remission in the progression of joint space outcomes using high-resolution peripheral quantitative CT ...
Eligibility Criteria
Inclusion
- fulfilled the 2010 ACR/EULAR classification criteria for RA
- have symptoms onset of less than 2 years,
- have active disease (SDAI \>3.3)
Exclusion
- have severe clinical deformity at the 2nd, 3rd or 4th MCP joint which precluded a reliable HR-pQCT examination and resulted in motion artefacts influencing the scanning accuracy
- are pregnant or breast feeding
Key Trial Info
Start Date :
July 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04324892
Start Date
July 12 2020
End Date
January 30 2024
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hopsital
Hong Kong, Hong Kong